Home › Mantle Cell Lymphoma › Tennessee › Nashville

Pag-aaral pangklinika para sa Mantle Cell Lymphoma sa Nashville, TN

Isang pag-aaral para sa Mantle Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Nashville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Tennessee Oncology, Pllc Nashville, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma

Nagre-recruitPhase 2

Vanderbilt University/Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07763210

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Nagre-recruitPhase 3

Tennessee Oncology Nashville St Thomas Midtown Clinic, Nashville
Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

Nagre-recruitPhase 2

Vanderbilt University/Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07003295

Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma

Nagre-recruitPhase 2

Vanderbilt University/Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07673367

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

TriStar BMT, Nashville

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT07121946

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Nashville

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Mantle Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.